Abbott Laboratories buy Piper Sandler
Start price
17.04.25
/
50%
€116.00
Target price
17.04.26
€127.60
Performance (%)
-29.40%
End price
18.04.26
€81.90
Summary
This prediction ended on 18.04.26 with a price of €81.90. The price of Abbott Laboratories has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -29.40%. Piper_Sandler has a follow-up prediction for Abbott Laboratories where he still thinks Abbott Laboratories is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | 2.271% | 2.271% | -16.610% |
| iShares Core DAX® | 1,84 % | 1,39 % | 8,65 % |
| iShares Nasdaq 100 | 4,66 % | -1,80 % | 27,82 % |
| iShares Nikkei 225® | 3,96 % | -5,22 % | 51,81 % |
| iShares S&P 500 | 3,70 % | 1,58 % | 24,09 % |
Comments by Piper_Sandler for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $145.00 price target on the stock, up previously from $133.00.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Abbott Laboratories
Stopped prediction by Piper_Sandler for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€77.32
22.06.26
22.06.26
€100.38
22.06.27
22.06.27
20.64%
19:08
19:08
Abbott Laboratories
Start price
Target price
Perf. (%)
€109.48
17.10.24
17.10.24
€122.61
17.10.25
17.10.25
0.46%
18.10.25
18.10.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€103.70
19.09.24
19.09.24
€117.72
19.09.25
19.09.25
12.09%
20.09.25
20.09.25